<code id='DBF9ADC8C9'></code><style id='DBF9ADC8C9'></style>
    • <acronym id='DBF9ADC8C9'></acronym>
      <center id='DBF9ADC8C9'><center id='DBF9ADC8C9'><tfoot id='DBF9ADC8C9'></tfoot></center><abbr id='DBF9ADC8C9'><dir id='DBF9ADC8C9'><tfoot id='DBF9ADC8C9'></tfoot><noframes id='DBF9ADC8C9'>

    • <optgroup id='DBF9ADC8C9'><strike id='DBF9ADC8C9'><sup id='DBF9ADC8C9'></sup></strike><code id='DBF9ADC8C9'></code></optgroup>
        1. <b id='DBF9ADC8C9'><label id='DBF9ADC8C9'><select id='DBF9ADC8C9'><dt id='DBF9ADC8C9'><span id='DBF9ADC8C9'></span></dt></select></label></b><u id='DBF9ADC8C9'></u>
          <i id='DBF9ADC8C9'><strike id='DBF9ADC8C9'><tt id='DBF9ADC8C9'><pre id='DBF9ADC8C9'></pre></tt></strike></i>

          Home / hotspot / hotspot

          hotspot


          hotspot

          author:Wikipedia    Page View:7
          Adam's take main illustration
          Molly Ferguson/STAT

          Biotech is awash in PIPEs.

          The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

          advertisement

          Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In